Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-29 · accession 0001348362-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-07-30 | 2025-07-29+ | LEXX | BUNKA CHRISTOPHER | Dir | P - Purchase | $0.9157 | +27.5K | 281.9K | +11% | +$25.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2025-07-29 | P | A | 15,600 | $0.92 | 270,012 | I Private Holding Company | — | — | |
| 2 | Common | common shares | 2025-07-30 | P | A | 11,900 | $0.91 | 281,912 | I Private Holding Company | — | — |